PA8567601A1 - B3-ADRENERGIC RECEPTOR AGONIST SALT, ITS FORMULATIONS AND ITS USES - Google Patents
B3-ADRENERGIC RECEPTOR AGONIST SALT, ITS FORMULATIONS AND ITS USESInfo
- Publication number
- PA8567601A1 PA8567601A1 PA20038567601A PA8567601A PA8567601A1 PA 8567601 A1 PA8567601 A1 PA 8567601A1 PA 20038567601 A PA20038567601 A PA 20038567601A PA 8567601 A PA8567601 A PA 8567601A PA 8567601 A1 PA8567601 A1 PA 8567601A1
- Authority
- PA
- Panama
- Prior art keywords
- salt
- monohidrate
- formulations
- procedures
- receptor agonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRESENTE INVENCION PROPORCIONA LA SAL TOSILATO DE (R)-2-(2-(4-OXAZOL-4-ILFENOXI)ETILAMINO)-1-PIRIDIN-3-ILETANOL), EL MONOHIDRATO DE DICHA SAL, PROCEDIMIENTOS UTILES EN LA PREPARCION DE DICHA SAL Y DICHO MONOHIDRATO, COMPOSICIONES FARMACEUTICAS QUE COMPRENDE DICHA SAL, O DICHO MONOHIDRATO, PROCEDIMIENTOS PARA TRATAR ENFERMEDADES, AFECCIONES Y TRASTORNOS EN UN MAMIFERO MEDIADOS POR EL RECEPTOR BETA 3 ADRENERGICO UTILIZANDO DICHA SAL, DICHO MONOHIDRATO O DICHAS COMPOSICIONES FARMACEUTICAS; Y PROCEDIMIENTOS PARA AUMENTAR EL CONTENIDO DE CARNE MAGRA EN ANIMALES COMESTIBLES UTILIZANDO DICHA SAL, DICHO MONOHIDRATO O DICHAS COMPOSICIONES FARMACEUTICAS.THIS INVENTION PROVIDES THE TOSILATE SALT OF (R) -2- (2- (4-OXAZOL-4-ILFENOXI) ETHYLAMINE) -1-PIRIDIN-3-ILETANOL), THE SALT MONOHIDRATE, USEFUL PROCEDURES IN THE PREPARATION OF SUCH SALT AND SUCH MONOHIDRATE, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH SALT, OR SUCH MONOHIDRATE, PROCEDURES TO TREAT DISEASES, AFFECTIONS AND DISORDERS IN A MAMIFIER MEDIATED BY THE BETA 3 ADRENERGIC RECEIVER USING DICHAICHO DICHAICHO COMPACT AND PROCEDURES TO INCREASE THE CONTENT OF MEAT MEAT IN EDIBLE ANIMALS USING SUCH SALT, SUCH MONOHIDRATE OR SUCH PHARMACEUTICAL COMPOSITIONS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36024802P | 2002-02-27 | 2002-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8567601A1 true PA8567601A1 (en) | 2003-12-10 |
Family
ID=27766205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20038567601A PA8567601A1 (en) | 2002-02-27 | 2003-02-26 | B3-ADRENERGIC RECEPTOR AGONIST SALT, ITS FORMULATIONS AND ITS USES |
Country Status (8)
| Country | Link |
|---|---|
| AR (1) | AR038603A1 (en) |
| AU (1) | AU2003248355A1 (en) |
| GT (1) | GT200300044A (en) |
| PA (1) | PA8567601A1 (en) |
| PE (1) | PE20030900A1 (en) |
| TW (1) | TW200305414A (en) |
| UY (1) | UY27678A1 (en) |
| WO (1) | WO2003072571A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9812709D0 (en) * | 1998-06-13 | 1998-08-12 | Glaxo Group Ltd | Chemical compounds |
| CA2423792A1 (en) * | 2000-10-20 | 2002-04-25 | Pfizer Products Inc. | Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
-
2003
- 2003-02-17 AU AU2003248355A patent/AU2003248355A1/en not_active Abandoned
- 2003-02-17 WO PCT/IB2003/000575 patent/WO2003072571A1/en not_active Application Discontinuation
- 2003-02-24 PE PE2003000179A patent/PE20030900A1/en not_active Application Discontinuation
- 2003-02-25 UY UY27678A patent/UY27678A1/en not_active Application Discontinuation
- 2003-02-25 AR ARP030100606A patent/AR038603A1/en not_active Application Discontinuation
- 2003-02-26 TW TW092104035A patent/TW200305414A/en unknown
- 2003-02-26 GT GT200300044A patent/GT200300044A/en unknown
- 2003-02-26 PA PA20038567601A patent/PA8567601A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR038603A1 (en) | 2005-01-19 |
| PE20030900A1 (en) | 2003-10-25 |
| UY27678A1 (en) | 2003-10-31 |
| AU2003248355A1 (en) | 2003-09-09 |
| GT200300044A (en) | 2003-09-22 |
| WO2003072571A1 (en) | 2003-09-04 |
| TW200305414A (en) | 2003-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0819690B8 (en) | use of a composition comprising cysteamine or cystamine, or a pharmaceutically acceptable salt thereof | |
| CL2004000257A1 (en) | HETEROCICLIL-3-SULFONILAZA-INDOL OR -INDAZOL COMPOUNDS; YOUR PHARMACEUTICAL COMPOSITION; YOUR PREPARATION PROCEDURE; AND ITS USE IN THE TREATMENT OF DISORDERS FOR ATTENTIONAL DEFICIT, ABSTINENCE PRODUCT OF ADDICTION TO DRUGS, ALCOHOL OR NICOTINE, AND | |
| HN2005000255A (en) | USED PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | |
| CR9514A (en) | NPY ANTAGONISTS, PREPARATION AND USES | |
| ECSP067021A (en) | COMPOUNDS AND COMPOSITIONS AS RECEPTOR MODULATORS ACTIVATED BY PEROXISOM PROLIFERATOR (PPAR) | |
| GT200300075AA (en) | COMPOUNDS THAT MODULATE PPAR ACTIVITY AND PROCEDURES FOR PREPARATION (FRACTIONARY PATENT NO. 1 OF APPLICATION NO. PI-20030075) | |
| MX2009002054A (en) | Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases. | |
| ECSP067019A (en) | COMPOUNDS AND COMPOSITIONS AS RECEPTOR MODULATORS ACTIVATED BY PEROXISOM PROLIFERATOR (PPAR) | |
| BRPI0413563A (en) | compounds and compositions as inhibitors of tyrosine kinase receptor activity | |
| DK1178736T3 (en) | Composition containing carvacrol and thymol for use as a bactericidal agent | |
| HN2004000319A (en) | "{1,8} NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA" | |
| CL2008003788A1 (en) | Pharmaceutical composition comprising a) the humanized b-ly1 antibody (anti-cd20 / human b-lymphocyte / bp35 restricted referencing antigen, type ii), b) optionally from 0.001% to 1% w / v of at least one surfactant, and c) 1 to 100 mm of a buffer; use to treat cd20-related diseases. | |
| GT200500378A (en) | MACROLIDOS | |
| CR7168A (en) | 5.HT RECEIVER LIGANDS AND THEIR USES | |
| CY1110922T1 (en) | COMPETITIVES OF GLUCAGON COMPETITORS, PREPARATION AND HEALTH USES | |
| CO6280440A2 (en) | AMINOBENZAMIDE DERIVATIVES AS USEFUL AGENTS FOR PARASITE CONTROL OF ANIMALS | |
| BR112012015961A2 (en) | compositions including pyruvate for pets and methods of use thereof | |
| AR049876A1 (en) | PHARMACEUTICAL COMPOSITIONS TO TREAT SKIN DISEASES THAT INCLUDE A COMBINATION OF EPINASTINE AND ONE OR MORE ADDITIONAL MINERALS OR ONE OR MORE GROSS PHARMACOS | |
| UY29790A1 (en) | DIARILOIMIDAZOLA-4-CARBOXAMID SALTS, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCESSES AND APPLICATIONS | |
| PA8600001A1 (en) | 4-PHENYL PIPERIDINE COMPOUNDS AND THEIR USES AS A MODULATOR OF THE OPIOID RECEPTORS | |
| CL2004000102A1 (en) | COMPOUNDS DERIVED FROM AMIDAS REPLACED BY CARBOCICLES, PHARMACEUTICAL COMPOSITION, USEFUL TO TREAT OBESITY, HYPERCOLESTEROLEMIA, DEPRESSION, SKIN DISEASES, CANCER OF THYROID AND OTHER. | |
| PT979224E (en) | SOLID COMPOUNDS SUITABLE FOR ORAL ADMINISTRATION COMPOSED BY L-CARNITINE OR MAGNESIUM ALCANOYL-L-CARNITINE | |
| PA8567601A1 (en) | B3-ADRENERGIC RECEPTOR AGONIST SALT, ITS FORMULATIONS AND ITS USES | |
| PA8567701A1 (en) | B3-ADRENERGIC RECEIVER AGONISTS | |
| PA8567501A1 (en) | CRYSTAL FORMS OF B3-ADRENERGIC RECEIVER AGONISTS, PROCEDURES FOR THEIR PREPARATION, AND THEIR USES |